Micheli Fabrizio, Pasquarello Alessandra, Tedesco Giovanna, Hamprecht Dieter, Bonanomi Giorgio, Checchia Anna, Jaxa-Chamiec Albert, Damiani Federica, Davalli Silvia, Donati Daniele, Gallotti Chiara, Petrone Marcella, Rinaldi Marilisa, Riley Graham, Terreni Silvia, Wood Martyn
GlaxoSmithKline Psychiatry Centre of Excellence for Drug Discovery, Via Fleming, 4, 37135 Verona, Italy.
Bioorg Med Chem Lett. 2006 Aug 1;16(15):3906-12. doi: 10.1016/j.bmcl.2006.05.034. Epub 2006 May 30.
Within the continuous quest for the discovery of novel compounds able to treat anxiety and depression, the generation of a pharmacophore model for 5-HT2C receptor antagonists and the discovery of a new class of potent and selective 5-HT2C molecules are reported.
在持续不断地探索能够治疗焦虑和抑郁的新型化合物的过程中,本文报道了5-HT2C受体拮抗剂药效团模型的构建以及一类新型强效且选择性的5-HT2C分子的发现。